2017 Publications
…KA (2017) Ghrelin and breast cancer: emerging roles in obesity, estrogen regulation, and cancer. Front Oncol 6:265. Bagheri-Fam S, Bird AD, Zhao L, Ryan JM, Yong M, Wilhelm D, Koopman…… Read more
…the team to test new drugs that will Lung cancer facts Every minute, one Australian dies from lung cancer Lung cancer is the most lethal cancer worldwide 1 in 10…… Read more
…KA (2017) Ghrelin and breast cancer: emerging roles in obesity, estrogen regulation, and cancer. Front Oncol 6:265. Bagheri-Fam S, Bird AD, Zhao L, Ryan JM, Yong M, Wilhelm D, Koopman…… Read more
Ovarian cancer is a silent killer. It is often asymptomatic and goes undetected until the advanced stages, when the cancer is widespread. Only a handful of new ovarian cancer treatment…… Read more
…a clinical trial for an ovarian cancer early detection test they developed, thanks to generous funding from the Ovarian Cancer Research Foundation (OCRF). Unlike a mammogram for breast cancer, or…… Read more
…the world’s population is infected with H. pylori, making it one of the most common bacterial infections. Stomach bacteria and cancer facts Stomach cancer is the fifth most common cancer…… Read more
…and activin A in the development of cancer-associated cachexia. Cancer Res. 76(18): 5372-82. Brooks GD, McLeod L, Alhayyani S, Miller A, Russell PA, Ferlin W, Rose-John S, Ruwanpura S, Jenkins…… Read more
…diagnosed by effective screening at an early stage (e.g. cervical cancer by a cervical screening test or breast cancer by mammography), an early detection test for ovarian cancer does not…… Read more
Dr Bilandzic, an ovarian cancer researcher, has been awarded $700,000 for research into deadly ovarian cancer cells called ‘leader cells’, which can survive and even thrive in response to cancer…… Read more
…to women with ovarian cancer.” Dr Maree Bilandzic New ovarian cancer treatments are long overdue Treatment for ovarian cancer has barely changed in 30 years. Dr Bilandzic has met women…… Read more
…A/Prof Simon Chu. Ovarian cancer is the most lethal gynaecological cancer Investing in high-potential research is the answer to increasing the survival rate of women. A/Prof Chu’s research on a…… Read more